What is the medical treatment for myocardial infarction (MI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Treatment of Myocardial Infarction

Immediately administer aspirin 160-325 mg, oxygen via nasal prongs, sublingual nitroglycerin (unless systolic BP <90 mmHg or HR <50 or >100 bpm), and morphine for pain control upon arrival to the emergency department. 1, 2

Initial Emergency Department Management (First 10-20 Minutes)

  • Perform a 12-lead ECG within 10 minutes of arrival to identify ST-segment elevation (≥1 mV in contiguous leads), which indicates thrombotic coronary occlusion and makes the patient a candidate for immediate reperfusion therapy 1, 2

  • Establish continuous cardiac monitoring with emergency resuscitation equipment (atropine, lidocaine, transcutaneous pacing patches, defibrillator, epinephrine) immediately available 1, 2

  • Administer aspirin 160-325 mg orally (or 300 mg per alternative protocols) immediately and continue indefinitely 1

  • Give sublingual nitroglycerin unless contraindicated by hypotension (systolic BP <90 mmHg) or heart rate abnormalities (<50 or >100 bpm) 1, 2

  • Provide adequate analgesia with morphine sulfate or meperidine to relieve chest pain and anxiety 1

  • Administer oxygen by nasal prongs to all patients 1, 2

Reperfusion Strategy Decision (Time-Critical)

The choice between primary PCI and thrombolytic therapy depends on time to treatment and facility capabilities:

Primary PCI (Preferred if Available)

  • Choose primary PCI if it can be performed within 90-120 minutes by skilled personnel with access to emergency CABG surgery 1, 2, 3
  • Primary PCI has superior outcomes compared to thrombolysis, with lower rates of reinfarction (8.5% vs 16.8% at 6 months) and intracranial hemorrhage (0% vs 2.0%) 4
  • The success rate for immediate PTCA is 97% when performed by experienced operators 4

Thrombolytic Therapy (If PCI Not Available)

  • Administer thrombolytic therapy within 30 minutes of arrival if primary PCI cannot be performed within 120 minutes 1, 3
  • Greatest benefit occurs when thrombolysis is initiated within the first hour of symptom onset (35 lives saved per 1,000 patients treated vs 16 lives saved per 1,000 when given 7-12 hours after onset) 1, 2
  • Thrombolytic therapy provides a 21% proportional reduction in 35-day mortality (21 deaths prevented per 1,000 patients treated) 1
  • Tissue plasminogen activator (tPA/alteplase) is preferred over streptokinase or urokinase due to fibrin specificity 1, 3
  • Do NOT give thrombolytic therapy to patients without ST-segment elevation - it provides no benefit and increases bleeding risk 1

Critical pitfall: Thrombolytic therapy increases risk of intracranial hemorrhage, particularly in patients >65 years, body weight <70 kg, systemic hypertension, or receiving tPA 1

Pharmacological Management: First 24 Hours

Beta-Blockers (Mortality Benefit)

  • Administer early intravenous beta-blocker therapy followed by oral therapy unless contraindicated 1, 2
  • For metoprolol: give three 5 mg IV bolus injections at 2-minute intervals, then start 50 mg orally every 6 hours for 48 hours, followed by 100 mg twice daily 5
  • Beta-blockers reduce morbidity and mortality regardless of whether reperfusion therapy was given 1
  • Monitor blood pressure, heart rate, and ECG during IV administration 5

Anticoagulation

  • Administer intravenous heparin 5,000 IU initially for patients receiving thrombolytic therapy or at high risk for embolic stroke 1
  • For patients with large anterior MI or LV mural thrombus on echocardiography, give IV heparin to reduce embolic stroke risk (9.0% vs 3.7% without anticoagulation) 1, 2
  • If alteplase (tPA) was given, continue IV heparin for 48 hours 1, 2
  • For streptokinase, evidence for additional heparin benefit beyond aspirin is limited 1

Nitroglycerin

  • Begin intravenous nitroglycerin for 24-48 hours if no hypotension, bradycardia, or excessive tachycardia 1, 2
  • IV nitroglycerin allows proper dose titration with frequent BP and heart rate monitoring 1
  • Do NOT use oral nitrates in the acute phase - inability to titrate dose in evolving hemodynamic situations is dangerous 1
  • Nitroglycerin should not substitute for narcotic analgesics 1

Antiplatelet Therapy Beyond Aspirin

  • Add clopidogrel 600 mg loading dose followed by daily maintenance (or consider prasugrel/ticagrelor if no bleeding risk) 1

Medications to AVOID

  • Do NOT give prophylactic antiarrhythmic agents in the first 24 hours 1, 2
  • Do NOT use calcium channel blockers - they have not reduced mortality and may be harmful 1

Management After First 24 Hours

Continue Core Medications

  • Aspirin 160-325 mg daily indefinitely 1, 2
  • Beta-blocker therapy for at least 6 weeks (continue indefinitely for long-term benefit) 1, 2
  • IV nitroglycerin for 24-48 hours total, then transition to oral if needed 1, 2
  • Magnesium sulfate as needed to replete deficits for 24 hours 1, 2

ACE Inhibitors (Mortality Benefit)

  • Start ACE inhibitor therapy (e.g., lisinopril 5 mg within 24 hours, then 5 mg after 24 hours, then 10 mg daily) for patients with anterior MI or left ventricular dysfunction 1, 2, 6
  • Reduce dose to 2.5 mg if systolic BP <120 mmHg at baseline 6
  • ACE inhibitors reduce 6-week mortality by 11% (6.4% vs 7.2%) 6
  • Monitor for hypotension and renal dysfunction (increased creatinine >3 mg/dL or doubling of baseline) 6

Activity Restrictions

  • Limit physical activities for at least 12 hours after admission 1, 2
  • Continuously monitor by electrocardiography as reinfarction and death occur most frequently within first 24 hours 1

Management of Complications

Recurrent Chest Pain

  • If due to pericarditis: high-dose aspirin 650 mg every 4-6 hours 1
  • If due to myocardial ischemia: IV nitroglycerin, analgesics, antithrombotic medications (aspirin, heparin), and consider coronary angiography with revascularization 1

Heart Failure

  • Administer IV furosemide (diuretic) and an afterload-reducing agent 1

Cardiogenic Shock

  • Insert intra-aortic balloon pump for hemodynamic support 1
  • Perform emergency coronary angiography followed by PTCA or CABG 1

Right Ventricular Infarction

  • Treat with vigorous intravascular volume expansion using normal saline and inotropic agents if hypotension persists 1

Special Considerations for Anterior MI

Anterior MI carries higher risk than inferior MI and requires heightened vigilance:

  • Higher risk for left ventricular dysfunction and heart failure 2, 3
  • Higher risk for LV mural thrombus formation leading to embolic stroke 2, 3
  • Higher risk for conduction disturbances and arrhythmias 2, 3
  • Perform echocardiography to evaluate LV function and detect mural thrombus 2, 3

Pre-Discharge Risk Stratification (Days 4-14)

  • Perform submaximal exercise testing at 4-7 days or symptom-limited testing at 10-14 days 1
  • This assesses functional capacity, evaluates medical regimen efficacy, and stratifies risk for subsequent cardiac events 1

Long-Term Management (Indefinite)

Medications

  • Continue aspirin indefinitely 1
  • Continue beta-blocker indefinitely 1
  • Continue ACE inhibitor at selected dose 1

Lipid Management

  • If LDL cholesterol >130 mg/dL despite diet, initiate drug therapy with goal of reducing LDL to <100 mg/dL 1

Lifestyle Modifications

  • Mandatory smoking cessation 1
  • Achieve ideal body weight 1
  • Diet low in saturated fat and cholesterol 1
  • Exercise at level of brisk walking for 20 minutes at least three times weekly 1
  • Participate in formal cardiac rehabilitation program 1

Critical Pitfalls to Avoid

  • Delaying reperfusion beyond the first hour dramatically reduces effectiveness (35 lives saved per 1,000 in first hour vs 16 lives saved per 1,000 at 7-12 hours) 1, 2, 3
  • Using oral nitrates instead of IV nitroglycerin in acute phase prevents proper dose titration 1, 2
  • Giving thrombolytics to patients without ST-elevation - no benefit and increased bleeding risk 1
  • Not having emergency equipment immediately available (atropine, lidocaine, pacing, defibrillator, epinephrine) 1, 2
  • Administering calcium channel blockers - no mortality benefit and potential harm 1, 2
  • Failing to transfer patients to PCI-capable center after fibrinolysis - all patients need angiography within 2-24 hours 3
  • Missing failed fibrinolysis - arrange rescue PCI immediately if reperfusion unsuccessful 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Anterior Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Thrombolytic Treatment for Acute Anterior Wall Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.